NuWave Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $515K | Buy |
+63,780
| New | +$515K | 0.59% | 57 |
|
|
2022
Q1 | – | Sell |
-22,648
| Closed | -$181K | – | 377 |
|
|
2021
Q4 | $181K | Buy |
+22,648
| New | +$181K | 0.21% | 155 |
|
|
2021
Q3 | – | Sell |
-16,740
| Closed | -$166K | – | 416 |
|
|
2021
Q2 | $166K | Buy |
+16,740
| New | +$166K | 0.18% | 170 |
|
|
2021
Q1 | – | Sell |
-15,308
| Closed | -$148K | – | 418 |
|
|
2020
Q4 | $148K | Sell |
15,308
-16,397
| -52% | -$159K | 0.19% | 143 |
|
|
2020
Q3 | $286K | Buy |
31,705
+31,157
| +5,686% | +$281K | 0.44% | 71 |
|
|
2020
Q2 | $7K | Buy |
+548
| New | +$7K | 0.01% | 351 |
|
|
2020
Q1 | – | Sell |
-22,823
| Closed | -$223K | – | 390 |
|
|
2019
Q4 | $223K | Sell |
22,823
-6,524
| -22% | -$63.7K | 0.22% | 159 |
|
|
2019
Q3 | $198K | Sell |
29,347
-2,371
| -7% | -$16K | 0.2% | 148 |
|
|
2019
Q2 | $293K | Buy |
31,718
+30,490
| +2,483% | +$282K | 0.31% | 105 |
|
|
2019
Q1 | $19K | Sell |
1,228
-22,848
| -95% | -$354K | 0.02% | 272 |
|
|
2018
Q4 | $371K | Buy |
+24,076
| New | +$371K | 0.63% | 57 |
|
|
2018
Q3 | – | Sell |
-159
| Closed | -$4K | – | 429 |
|
|
2018
Q2 | $4K | Buy |
+159
| New | +$4K | 0.01% | 249 |
|
|
2018
Q1 | – | Sell |
-102
| Closed | -$2K | – | 349 |
|
|
2017
Q4 | $2K | Buy |
+102
| New | +$2K | ﹤0.01% | 322 |
|
|
2014
Q3 | $59K | Buy |
1,087
+903
| +491% | +$49K | 0.17% | 141 |
|
|
2014
Q2 | $10K | Sell |
184
-6,066
| -97% | -$330K | 0.03% | 248 |
|
|
2014
Q1 | $331K | Buy |
6,250
+6,191
| +10,493% | +$328K | 0.98% | 25 |
|
|
2013
Q4 | $2K | Sell |
59
-164
| -74% | -$5.56K | ﹤0.01% | 287 |
|
|
2013
Q3 | $8K | Sell |
223
-13,962
| -98% | -$501K | 0.01% | 268 |
|
|
2013
Q2 | $556K | Buy |
+14,185
| New | +$556K | 0.61% | 64 |
|